This website is intended for healthcare professionals

Gene editing therapy

NHS to offer ‘life-changing’ gene-editing therapy for thalassaemia

Trials found that 93% of patients did not need blood transfusions after treatment, which has been described as a ‘historic moment’ for people with thalassaemia

Why choose British Journal of Nursing?

BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.

What's included

  • Clinical expertise

  • Peer-reviewed research

  • Best practice guidance

  • CPD support

Subscriptions start:

From £13.75 GBP